Asthma and Severe Asthma Epidemiology Analysis and Forecast to 2033
Powered by ![]()
All the vital news, analysis, and commentary curated by our industry experts.
Asthma and Severe Asthma Report Overview
In the 8MM, there were 56,552,679 12-month diagnosed prevalent cases of asthma in 2023. The diagnosed prevalent cases will register an AGR of less than 1% during 2023-2033. Asthma is a common lung condition characterized by the narrowing and swelling of the lungs’ airways and the production of excess mucus. Common asthma symptoms include wheezing, breathlessness, chest tightness, and coughing at night or early in the morning.
Asthma and Severe Asthma Market Outlook, 2023-2033 (Diagnosed Prevalent Cases)
Buy the Full Report for More Insights into the Asthma and Severe Asthma Market Forecast
The asthma and severe asthma market research report provides an overview of the risk factors, comorbidities, and global trends of asthma and severe asthma in the eight major markets (8MM: US, France, Germany, Italy, Spain, UK, Japan, and China). The report includes a 10-year epidemiological forecast for the 12-month and lifetime diagnosed prevalent cases of asthma and severe asthma, segmented by age and sex.
| Market Size (2023) | 56,552,679 Cases |
| AGR (2023-2033) | <1% |
| Forecast Period | 2023-2033 |
| Key Countries | · The US
· France · Germany · Spain · Italy · The UK · Japan · China |
| Key Sex Segments | · Men
· Women |
| Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Asthma and Severe Asthma Market Segmentation by Country
The key countries across the 8MM are the US, France, Germany, Spain, Italy, the UK, Japan, and China. In 2023, the US accounted for the highest number of diagnosed prevalent cases of asthma and severe asthma in the 8MM. Any change in the diagnosed prevalent cases of asthma is attributable to changing population demographics and changing diagnosed prevalence rates based on trend analysis in the 8MM.
Asthma and Severe Asthma Market Analysis by Country, 2023 (%)
Buy the Full Report for More Country Insights into the Asthma and Severe Asthma Market
Download a Free Report Sample
Asthma and Severe Asthma Market Segmentation by Sex Type
Based on sex, the market can be segmented into men and women. In 2023, the number of 12-month diagnosed prevalent cases of asthma was higher in women than in men in the 8MM combined. Japan had the smallest variation in the number of diagnosed prevalent cases between men and women.
Asthma and Severe Asthma Market Analysis by Sex, 2023 (%)
Buy the Full Report for More Sex Type Insights into the Asthma and Severe Asthma Market
Segments Covered in the Report
Asthma and Severe Asthma Country Outlook (Diagnosed Prevalent Cases)
- The US
- France
- Germany
- Spain
- Italy
- The UK
- Japan
- China
Asthma and Severe Asthma Sex Outlook (Diagnosed Prevalent Cases)
- Men
- Women
Scope
The Asthma and Severe Asthma Epidemiology Report and Model provide an overview of the risk factors, comorbidities, and global trends of asthma and severe asthma in the eight major markets (8MM: US, France, Germany, Italy, Spain, UK, Japan, and China).
The report includes a 10-year epidemiological forecast for the 12-month and lifetime diagnosed prevalent cases of asthma and severe asthma, segmented by age (0 years up to 80 years older by 10-year age groups) and sex. The 12-month and lifetime diagnosed prevalent cases of severe asthma are further segmented by inflammatory subtype (atopic or allergic asthma, eosinophilic or neutrophilic).
Reasons to Buy
The asthma and severe asthma epidemiology series will allow you to:
- Develop business strategies by understanding the trends shaping and driving the global asthma and severe asthma markets.
- Quantify patient populations in the global asthma and severe asthma markets to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for asthma and severe asthma therapeutics in each of the market covered.
- Understand the magnitude of the asthma and severe asthma population by age and sex and the severe asthma population by inflammatory subtype.
Table of Contents
Table
Figures
Frequently asked questions
-
How many diagnosed prevalent cases of asthma were seen in the 8MM in 2023?
In 2023, there were 56,552,679 12-month diagnosed prevalent cases of asthma in the 8MM.
-
What will the growth rate of the asthma market be during the forecast period?
The diagnosed prevalent cases of asthma will register an AGR of less than 1% during 2023-2033.
-
Which was the leading country in the asthma and severe asthma market in 2023?
In 2023, the US accounted for the highest number of diagnosed prevalent cases of asthma and severe asthma in the 8MM.
-
Which was the leading sex segment in the asthma and severe asthma market in 2023?
In 2023, the number of 12-month diagnosed prevalent cases of asthma was higher in women than in men in the 8MM combined.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Related reports
View more Asthma reports


